BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6113670)

  • 1. [Research on the prognostic value of immunodeficiency in Hodgkin's disease].
    Szász B; Dudea C; Róna L; Kifor I; Borsai G; Zegrean G; Rad L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):511-20. PubMed ID: 6113670
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
    Eltringham JR; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating lymphoid cells in Hodgkin's disease.
    Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():95-8. PubMed ID: 4270378
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of phytohemagglutinin on lymphocytes in Hodgkin's disease].
    Eggerth G; Kühböck J; Pokorny D
    Wien Z Inn Med; 1969; 50(7):314-9. PubMed ID: 5380683
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunodeficiency in Hodgkin's disease and its relation to prognosis.
    Björkholm M
    Scand J Haematol Suppl; 1978; 33():1-74. PubMed ID: 305101
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the immunological status of patients with Hodgkin's disease].
    Rambotti P; Velardi A; Spinozzi F; Aversa F; Falini B
    Ann Sclavo; 1978; 20(3):225-38. PubMed ID: 310660
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phytohaemagglutinin culture as a serial control of lymphoproliferative diseases (author's transl)].
    Boll I; Kötter R; Aust C
    Dtsch Med Wochenschr; 1974 Apr; 99(14):678-84. PubMed ID: 4601034
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro leukocyte interferon production in patients with Hodgkin's disease.
    Rassiga-Pidot AL; McIntyre OR
    Cancer Res; 1974 Nov; 34(11):2995-3002. PubMed ID: 4421578
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cellular immune response and concentrations of serum immunoglobulins in patients with Hodgkin's disease (author's transl)].
    Stefanits K; Kuhn E; Ambrus M; Csere T
    Strahlentherapie; 1979 May; 155(5):335-40. PubMed ID: 442117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of cell-mediated immunity to staging, histology and prognosis in untreated patients with Hodgkin's disease.
    De Gast GC; Halie MR
    Neth J Med; 1976; 19(4-5):196-200. PubMed ID: 980187
    [No Abstract]   [Full Text] [Related]  

  • 18. Skin reactivity to bacterial antigens in Hodgkin's disease.
    Rasiewicz W; Kardaszewicz E
    Pol Med J; 1969; 8(5):1203-8. PubMed ID: 5383935
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinguishing features of the immunology of Hodgkin's disease in children.
    Tan CT; De Sousa M; Good RA
    Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the bone marrow granulocyte reserve in patients with Hodgkin's disease during antiblastic polychemo- and radiation therapy].
    Santagati G; Nicolini E; Zibetti G; Paladini G
    Minerva Med; 1978 May; 69(25):1739-43. PubMed ID: 662176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.